
No transactions found.
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Sales | $34.1M-10.2% | $38.0M-15.1% | $44.7M-15.7% | $53.0M+6.9% | $49.6M |
| Cost of goods sold | $25.1M-4.6% | $26.3M-17.5% | $31.9M-22.1% | $40.9M+13.7% | $36.0M |
| Inventory write-offs | $2.0M+626.7% | $277K | — | — | — |
| Total cost of goods sold | $27.1M+2.0% | $26.6M | — | — | — |
| Gross profit | $7.0M-38.8% | $11.4M+17.1% | $9.7M-19.8% | $12.1M-10.9% | $13.6M |
| Delivery and handling expense | $5.4M-8.3% | $5.9M-22.5% | $7.6M-34.8% | $11.6M-2.8% | $11.9M |
| Selling and marketing expense | $5.3M+19.7% | $4.4M-9.5% | $4.9M-33.5% | $7.3M-24.3% | $9.7M |
| General and administrative expense | $11.3M+24.0% | $9.1M+48.9% | $6.1M-18.3% | $7.5M-6.0% | $8.0M |
| Provision for receivable with former related party | $169K+47.0% | $115K-80.3% | $585K+8.7% | $538K | — |
| Total operating expenses | $22.1M+13.4% | $19.5M+1.9% | $19.1M-29.0% | $26.9M-8.9% | $29.6M |
| Loss from operations | -$15.1M-86.6% | -$8.1M+13.8% | -$9.4M+36.5% | -$14.8M+7.1% | -$16.0M |
| Other Income | $414K-7.0% | $445K | — | — | — |
| Interest expense, net | -$1.1M+79.8% | -$5.5M+10.2% | -$6.1M-16.9% | -$5.2M-334.9% | -$1.2M |
| Net loss | -$15.8M-20.5% | -$13.2M+15.3% | -$15.5M+22.6% | -$20.1M-22.3% | -$16.4M |
| Dividends on Series A Convertible Preferred Stock | -$5K+0.0% | -$5K+0.0% | -$5K+0.0% | -$5K+0.0% | -$5K |
| Net loss attributable to common stockholders | -$15.8M-20.4% | -$13.2M+15.3% | -$15.5M+22.6% | -$20.1M-22.3% | -$16.4M |
| Loss per share - basic | -$2K+80.5% | -$10K-123.5% | -$4K+51.6% | -$9K-0.9% | -$9K |
| Loss per share - diluted | -$2K+80.5% | -$10K-123.5% | -$4K+51.6% | -$9K | — |
| Weighted average number of shares outstanding - basic | $8.30B+519.4% | $1.34B-62.1% | $3.54B+60.0% | $2.21B+21.2% | $1.82B |
| Weighted average number of shares outstanding - diluted | $8.30B+519.4% | $1.34B-62.1% | $3.54B+60.0% | $2.21B | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Track Russell 3000 REIT shuffle: Reed's slated for addition as Skinhealth System exits
Zscaler upgraded, CoreWeave downgraded: Wall Street's top analyst calls
Reed's Inc (REED) Q1 2026 Earnings Call Highlights: Strategic Initiatives and Operational Challenges
Reed’s expects sequential improvement in net sales, gross margin and net loss as it reverses key packaging discontinuations